(Q39205134)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23348596%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

title

The antimalarial ferroquine is an inhibitor of hepatitis C virus (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23348596%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

0 references

1 reference

1 reference

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23348596%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Yann Guérardel

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23348596%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Jean Dubuisson

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23348596%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Sandrine Belouzard

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23348596%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

François Helle

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23348596%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Ahmed M. Wahid

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23348596%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Laurence Cocquerel

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23348596%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Christophe Biot

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23348596%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

4

Véronique Descamps

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23348596%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

14

Czeslaw Wychowski

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23348596%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

2

Noémie Calland

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23348596%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

9

Gilles Duverlie

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23348596%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

5

Florian Douam

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23348596%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

1

Thibaut Vausselin

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23348596%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

11

Lucie Fénéant

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23348596%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

7

Catherine François

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23348596%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

language of work or name

English

0 references

publication date

14 May 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23348596%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23348596%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

volume

58

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23348596%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23348596%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

page(s)

86-97

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23348596%20AND%20SRC:MED&resulttype=core&format=json

Evolving epidemiology of hepatitis C virus

22 February 2020

cites work

1 reference

New direct-acting antivirals' combination for the treatment of chronic hepatitis C.

21 January 2018

1 reference

Oral combination therapy with a nucleoside polymerase inhibitor (RG7128) and danoprevir for chronic hepatitis C genotype 1 infection (INFORM-1): a randomised, double-blind, placebo-controlled, dose-escalation trial

21 January 2018

1 reference

Preliminary study of two antiviral agents for hepatitis C genotype 1.

21 January 2018

1 reference

Characterization of Low- and Very-Low-Density Hepatitis C Virus RNA-Containing Particles

21 January 2018

1 reference

Hepatitis C Virus Entry Depends on Clathrin-Mediated Endocytosis

21 January 2018

1 reference

Hepatitis C virus cell-cell transmission in hepatoma cells in the presence of neutralizing antibodies

21 January 2018

1 reference

CD81 is dispensable for hepatitis C virus cell-to-cell transmission in hepatoma cells

21 January 2018

1 reference

Synthesis and antimalarial activity in vitro and in vivo of a new ferrocene-chloroquine analogue.

21 January 2018

1 reference

The antimalarial ferroquine: from bench to clinic

21 January 2018

1 reference

Design and synthesis of hydroxyferroquine derivatives with antimalarial and antiviral activities.

21 January 2018

1 reference

Characterization of monoclonal antibodies to bovine viral diarrhoea virus: evidence of a neutralizing activity against gp48 in the presence of goat anti-mouse immunoglobulin serum

21 January 2018

1 reference

Production of infectious hepatitis C virus in tissue culture from a cloned viral genome

21 January 2018

1 reference

Identification of GBF1 as a Cellular Factor Required for Hepatitis C Virus RNA Replication

21 January 2018

1 reference

Robust production of infectious viral particles in Huh-7 cells by introducing mutations in hepatitis C virus structural proteins

21 January 2018

1 reference

The CD81 Partner EWI-2wint Inhibits Hepatitis C Virus Entry

21 January 2018

1 reference

Characterization of functional hepatitis C virus envelope glycoproteins.

21 January 2018

1 reference

Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras

21 January 2018

1 reference

Neutralizing antibody-resistant hepatitis C virus cell-to-cell transmission

21 January 2018

1 reference

Griffithsin has antiviral activity against hepatitis C virus

21 January 2018

1 reference

Subcellular localization of hepatitis C virus structural proteins in a cell culture system that efficiently replicates the virus

21 January 2018

1 reference

Identification of basic amino acids at the N-terminal end of the core protein that are crucial for hepatitis C virus infectivity

21 January 2018

1 reference

TaqMan amplification system with an internal positive control for HCV RNA quantitation

21 January 2018

1 reference

Role of low-density lipoprotein receptor in the hepatitis C virus life cycle

21 January 2018

1 reference

Glucocorticosteroids increase cell entry by hepatitis C virus

21 January 2018

1 reference

Characterization of Fusion Determinants Points to the Involvement of Three Discrete Regions of Both E1 and E2 Glycoproteins in the Membrane Fusion Process of Hepatitis C Virus

21 January 2018

1 reference

Evaluation of combination chemotherapy: integration of nonlinear regression, curve shift, isobologram, and combination index analyses

21 January 2018

1 reference

A three-dimensional model to analyze drug-drug interactions

21 January 2018

1 reference

New advances in the molecular biology of hepatitis C virus infection: towards the identification of new treatment targets

21 January 2018

1 reference

Insights into the mechanism of action of ferroquine. Relationship between physicochemical properties and antiplasmodial activity.

21 January 2018

1 reference

Foamy virus envelope glycoprotein-mediated entry involves a pH-dependent fusion process

21 January 2018

1 reference

The antimalarial ferroquine: role of the metal and intramolecular hydrogen bond in activity and resistance

21 January 2018

1 reference

Investigation of the redox behavior of ferroquine, a new antimalarial

21 January 2018

1 reference

Characterization of the envelope glycoproteins associated with infectious hepatitis C virus

21 January 2018

1 reference

Inhibition of hepatitis C virus replication by chloroquine targeting virus-associated autophagy.

21 January 2018

1 reference

Impact of the autophagy machinery on hepatitis C virus infection

21 January 2018

1 reference

Pharmacokinetics of ferroquine, a novel 4-aminoquinoline, in asymptomatic carriers of Plasmodium falciparum infections

21 January 2018

1 reference

Hepatitis C virus entry into the hepatocyte

21 January 2018

1 reference

Hepatitis C and liver transplantation

21 January 2018

1 reference

Characterization of hepatitis C virus E2 glycoprotein interaction with a putative cellular receptor, CD81.

21 January 2018

1 reference

12 December 2020

Infectious cell entry mechanism of influenza virus.

1 reference

12 December 2020

Formation and intracellular localization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia and Sindbis viruses

1 reference

12 December 2020

Effects of lysosomotropic weak bases on infection of BHK-21 cells by Sindbis virus.

1 reference

12 December 2020

Growth of human hepatoma cells lines with differentiated functions in chemically defined medium

1 reference

12 December 2020

In situ nanochemical imaging of label-free drugs: a case study of antimalarials in Plasmodium falciparum-infected erythrocytes

1 reference

12 December 2020

Identifiers

DOI

10.1002/HEP.26273

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23348596%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

PMC publication ID

7165689

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23348596%20AND%20SRC:MED&resulttype=core&format=json